Insight Molecular Diagnostics (IMDX) Shares Outstanding: 2020-2025
Historic Shares Outstanding for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $28.6 million.
- Insight Molecular Diagnostics' Shares Outstanding rose 114.03% to $28.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.6 million, marking a year-over-year increase of 114.03%. This contributed to the annual value of $17.5 million for FY2024, which is 111.27% up from last year.
- Per Insight Molecular Diagnostics' latest filing, its Shares Outstanding stood at $28.6 million for Q3 2025, which was up 0.03% from $28.6 million recorded in Q2 2025.
- Insight Molecular Diagnostics' Shares Outstanding's 5-year high stood at $92.2 million during Q3 2021, with a 5-year trough of $4.6 million in Q4 2021.
- Moreover, its 3-year median value for Shares Outstanding was $13.4 million (2024), whereas its average is $15.4 million.
- Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 136,935.88% in 2021, then slumped by 94.81% in 2022.
- Over the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Quarterly) stood at $4.6 million in 2021, then increased by 28.62% to $5.9 million in 2022, then soared by 39.26% to $8.3 million in 2023, then spiked by 111.27% to $17.5 million in 2024, then soared by 114.03% to $28.6 million in 2025.
- Its last three reported values are $28.6 million in Q3 2025, $28.6 million for Q2 2025, and $28.6 million during Q1 2025.